To investigate hepatic IGF-1 content in all stages of chronic liver disease, we performed comparative analysis of protein expression of TLR7, LC3A/B, and IGF-1 in livers from mice under normal, NAFLD, and cirrhosis conditions (Fig. S8). Here, MAP1LC3A is linked to Cirrhosis.